Rachel Power

Rachel Power, as the Chief Executive of The Patients Association, is a prominent voice advocating for patient rights and safety within the UK's National Health Service (NHS). Her current newsworthiness stems from her organization's critical stance on recent NHS developments that could impact patient care and data privacy. Specifically, The Patients Association, under Power's leadership, has expressed concerns regarding the record-high waiting times for diagnostic tests in England, as highlighted in recent news. These delays, affecting millions of patients, raise fears of potential harm due to delayed diagnoses. Furthermore, Power has been vocal about the "dangerous" decision by NHS England to grant Palantir access to identifiable patient data. She emphasizes that such moves risk eroding public trust and suggest that data privacy is not being adequately prioritized. Her ongoing relevance lies in her role as a patient advocate, ensuring that the experiences and concerns of those using the NHS are heard and addressed amidst significant systemic challenges and technological advancements.